Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE119291 | GEO | 2018/10/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia.

Project description:A lack of biologically relevant screening models hinders the discovery of better treatments for schizophrenia (SZ) and other neuropsychiatric disorders. Here we compare the transcriptional responses of 8 commonly used cancer cell lines (CCLs) directly with that of human induced pluripotent stem cell (hiPSC)-derived neural progenitor cells (NPCs) from 12 individuals with SZ and 12 controls across 135 drugs, generating 4320 unique drug-response transcriptional signatures. We identify those drugs that reverse post-mortem SZ-associated transcriptomic signatures, several of which also differentially regulate neuropsychiatric disease-associated genes in a cell type (hiPSC NPC vs. CCL) and/or a diagnosis (SZ vs. control)-dependent manner. Overall, we describe a proof-of-concept application of transcriptomic drug screening to hiPSC-based models, demonstrating that the drug-induced gene expression differences observed with patient-derived hiPSC NPCs are enriched for SZ biology, thereby revealing a major advantage of incorporating cell type and patient-specific platforms in drug discovery.

| S-EPMC6200740 | biostudies-literature

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA202]

Project description:Integration of in silico and in vitro approaches to design and conduct transcriptomic drug screening in patient-derived neural cells, in order to survey novel pathologies and points of intervention in schizophrenia.

2018-10-31 | GSE119284 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA201]

2018-10-31 | GSE119283 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA108]

2018-10-31 | GSE119282 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA107]

2018-10-31 | GSE119281 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA105]

2018-10-31 | GSE119279 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA104]

2018-10-31 | GSE119278 | GEO

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA103]